{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T04:04:14Z","timestamp":1648785854550},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.jgyn.2012.11.012","type":"journal-article","created":{"date-parts":[[2013,1,8]],"date-time":"2013-01-08T23:27:22Z","timestamp":1357687642000},"page":"232-237","source":"Crossref","is-referenced-by-count":3,"title":["Traitement d\u2019une hyperthyro\u00efdie secondaire \u00e0 une maladie de Basedow\u00a0: quel antithyro\u00efdien de synth\u00e8se au cours de la grossesse\u00a0?"],"prefix":"10.1016","volume":"42","author":[{"given":"P.","family":"Caron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgyn.2012.11.012_bib0005","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/thy.1994.4.129","article-title":"Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis","volume":"4","author":"Mandel","year":"1994","journal-title":"Thyroid"},{"key":"10.1016\/j.jgyn.2012.11.012_bib0010","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1210\/er.2009-0041","article-title":"Thyroid function and human reproductive health","volume":"31","author":"Krassas","year":"2010","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jgyn.2012.11.012_bib0015","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijgo.2009.08.006","article-title":"Pregnancy and perinatal outcome in women with hyperthyroidism","volume":"108","author":"Pillar","year":"2010","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jgyn.2012.11.012_bib0020","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1002\/ajmg.a.32497","article-title":"Choanal atresia associated with maternal hyperthyroidism treated with methimazole: a case-control study","volume":"146A","author":"Barbero","year":"2008","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jgyn.2012.11.012_bib0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/s-2003-38320","article-title":"Gastrointestinal malformations in two infants born to women with hyperthyroidism untreated in the first trimester","volume":"20","author":"Seoud","year":"2003","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.jgyn.2012.11.012_bib0030","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2265.1984.tb00119.x","article-title":"Maternal hyperthyroidism and congenital malformation in offspring","volume":"20","author":"Momotani","year":"1984","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.jgyn.2012.11.012_bib0035","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1210\/jc.2011-2860","article-title":"Treatment of Graves\u2019 disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation","volume":"97","author":"Yoshihara","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jgyn.2012.11.012_bib0040","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1210\/jc.2012-2123","article-title":"Antithyroid drug treatment in pregnancy","volume":"97","author":"Lazarus","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jgyn.2012.11.012_bib0045","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra042972","article-title":"Antithyroid drugs","volume":"352","author":"Cooper","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgyn.2012.11.012_bib0050","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0002-9378(94)70390-6","article-title":"\u00c0 comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy","volume":"170","author":"Wing","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jgyn.2012.11.012_bib0055","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1345\/aph.1H535","article-title":"Propylthiouracil versus methimazole in treatment of Graves\u2019 disease during pregnancy","volume":"41","author":"Chattaway","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jgyn.2012.11.012_bib0060","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJM198607033150104","article-title":"Antithyroid drug therapy for Graves\u2019 disease during pregnancy. Optimal regimen for fetal thyroid status","volume":"315","author":"Momotani","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgyn.2012.11.012_bib0065","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1210\/jc.82.9.3099","article-title":"Methimazole and propylthiouracil equally cross the perfused human term placental lobule","volume":"82","author":"Mortimer","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jgyn.2012.11.012_bib0070","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/tera.1420050117","article-title":"Maternal methimazole and congenital defects in children","volume":"5","author":"Milham","year":"1972","journal-title":"Teratology"},{"key":"10.1016\/j.jgyn.2012.11.012_bib0075","first-page":"575","article-title":"Aplasia cutis after exposure to carbimazole in utero","volume":"20","author":"Dutertre","year":"1991","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.jgyn.2012.11.012_bib0080","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/j.1365-2133.1995.tb06940.x","article-title":"Aplasia cutis congenital after exposure to methimazole: a causal relationship?","volume":"133","author":"Vogt","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jgyn.2012.11.012_bib0085","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2273.2005.01046.x","article-title":"Choanal atresia-a recurrent feature of f\u0153tal carbimazole syndrome","volume":"30","author":"Myers","year":"2005","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.jgyn.2012.11.012_bib0090","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/235130","article-title":"Suspected spontaneous reports of birth defects in the UK associated with the use of carbimazole and propylthiouracil in pregnancy","author":"Bowman","year":"2011","journal-title":"J Thyroid Res"},{"key":"10.1016\/j.jgyn.2012.11.012_bib0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/(SICI)1096-8628(19990305)83:1<43::AID-AJMG8>3.0.CO;2-C","article-title":"Methimazole embryopathy: delineation of the phenotype","volume":"83","author":"Clementi","year":"1999","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jgyn.2012.11.012_bib0100","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/qjmed\/hcq248","article-title":"Carbimazole embryopathy: implications for the choice of antithyroid drugs in pregnancy","volume":"105","author":"Bowman","year":"2012","journal-title":"Q J Med"},{"key":"10.1016\/j.jgyn.2012.11.012_bib0105","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/tera.1072","article-title":"Adverse effects of prenatal methimazole exposure","volume":"64","author":"Di Gianantonio","year":"2001","journal-title":"Teratology"},{"key":"10.1016\/j.jgyn.2012.11.012_bib0110","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/j.1471-0528.2011.03019.x","article-title":"Risks of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nation wide population-based study","volume":"118","author":"Chen","year":"2011","journal-title":"BJOG"},{"key":"10.1016\/j.jgyn.2012.11.012_bib0115","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1210\/jc.87.2.947-a","article-title":"Severe embryopathy and exposure to methimazole in early pregnancy","volume":"87","author":"Karlsson","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jgyn.2012.11.012_bib0120","doi-asserted-by":"crossref","first-page":"E337","DOI":"10.1210\/jc.2010-0652","article-title":"Treatment of hyperthyroidism in pregnancy and birth defects","volume":"95","author":"Clementi","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jgyn.2012.11.012_bib0125","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1515\/jpem.2011.099","article-title":"Aplasia cutis congenita in surviving co-twin after propylthiouracil exposure in utero","volume":"24","author":"L\u00f6llgen","year":"2011","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jgyn.2012.11.012_bib0130","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1089\/thy.2009.0169","article-title":"The Role of propylthiouracil in the management of Graves\u2019 disease in adults: report of a meeting jointly sponsored by the American thyroid association and the food and drug administration","volume":"19","author":"Bahn","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.jgyn.2012.11.012_bib0135","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1210\/jc.2009-0850","article-title":"Putting propylthiouracil in perspective","volume":"94","author":"Cooper","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jgyn.2012.11.012_bib0140","unstructured":"Statement FDA (Medwatch Online). Information for healthcare professionals: propylthiouracil-induced liver failure. 2009. http:\/\/www.fda.gov\/Drugs\/DrugSafety\/Postmarket Drug Safety Information for Patients and Providers\/DrugSafety Information for Heathcare Professionals\/ucm162701.html (accessed June 17, 2010)."},{"key":"10.1016\/j.jgyn.2012.11.012_bib0145","first-page":"311","article-title":"An unusual presentation of fulminant hepatic failure secondary to propylthiouracil therapy","author":"Morris","year":"1989","journal-title":"Clin Transpl"},{"key":"10.1016\/j.jgyn.2012.11.012_bib0150","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1345\/aph.1A408","article-title":"Fulminant hepatic failure associated with propylthiouracil","volume":"37","author":"Ruiz","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jgyn.2012.11.012_bib0155","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000336071","article-title":"A case of propylthiouracil-induced hepatitis during pregnancy","volume":"1","author":"Taylor","year":"2012","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.jgyn.2012.11.012_bib0160","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1186\/1752-1947-5-461","article-title":"Severe propylthiouracil-induced hepatotoxicity in pregnancy managed successfully by liver transplantation: a case report","volume":"19","author":"Sequeira","year":"2011","journal-title":"J Med Case Reports."},{"key":"10.1016\/j.jgyn.2012.11.012_bib0165","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2007-0141","article-title":"Management of thyroid dysfunction during pregnancy and postpartum: an endocrine society clinical practice guideline","volume":"92","author":"Abalovich","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jgyn.2012.11.012_bib0170","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1089\/thy.2011.0087","article-title":"Guidelines of the american thyroid association for the diagnosis and management of thyroid disease during pregnancy and postpartum","volume":"21","author":"Stagnaro-Green","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/j.jgyn.2012.11.012_bib0175","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4158\/EP.17.3.456","article-title":"Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the american thyroid association and american association of clinical endocrinologists","volume":"17","author":"Bahn","year":"2011","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jgyn.2012.11.012_bib0180","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4158\/EP09233.RA","article-title":"Graves hyperthyroidism and pregnancy: a clinical update","volume":"16","author":"Patil-Sisodia","year":"2010","journal-title":"Endocr Prac"},{"key":"10.1016\/j.jgyn.2012.11.012_bib0185","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/MED.0b013e3283565b49","article-title":"The propylthiouracil dilemma","volume":"19","author":"Glinoer","year":"2012","journal-title":"Curr Opin Endocrinol Diabetes Obes"}],"container-title":["Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0368231512003729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0368231512003729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T12:32:31Z","timestamp":1539952351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0368231512003729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0368231512003729"],"URL":"https:\/\/doi.org\/10.1016\/j.jgyn.2012.11.012","relation":{},"ISSN":["0368-2315"],"issn-type":[{"value":"0368-2315","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}